An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis

Abroad (travel likely)RecruitingPHASE2

Conditions

Rheumatoid Arthritis (RA) · Rheumatology

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Singapore General Hospital, Singapore, Singapore
Contact: Study coordinator (Chin Teck NG, MD) · ng.chin.teck@singhealth.com.sg · +65 6321 4028

Study leads

Salvatore Albani, MD PhD
Principal Investigator
Singapore Health Services

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis

Rheumatoid Arthritis · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE2

Al Mansurah, Egypt

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Study With CIT-013 in RA Patients

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE2

Antwerp, Belgium · Leuven, Belgium

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE2

Cutler Bay, United States · Miami, United States